iTonic Holdings (ITOC) Equity Average (2024 - 2025)

iTonic Holdings' (ITOC) quarterly Equity Average came in at $6.4 million in Q4 2025, up 98.1% year-on-year from $3.2 million in Q4 2024, and up 17.79% quarter-over-quarter from $5.5 million in Q2 2025.

iTonic Holdings (ITOC) Equity Average (2024 - 2025) Analysis & Trends

iTonic Holdings has disclosed Equity Average across 2 years of filings, most recently posting $6.4 million for Q4 2025.

  • Equity Average for Q4 2025 came in at $6.4 million, up 98.1% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.4 million (up 98.1% YoY), and the FY2025 annual result was $7.2 million, up 120.48% from the prior year.
  • Equity Average came in at $6.4 million for Q4 2025 at iTonic Holdings, up from $5.5 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $6.4 million in Q4 2025 to a low of $3.2 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 52.42 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 22.70 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 49.03 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 25.17 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 10.33 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 13.05 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 2.85 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.53 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 7.18 Bn
10 iTonic Holdings 5.23 Mn 4.31 Mn - 6.43 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 6.43 Mn
Jun 30, 2025 5.46 Mn
Dec 31, 2024 3.25 Mn